Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...

Please provide your email address to receive an email when new articles are posted on . The AD2 blood test was roughly 90% accurate at Alzheimer’s identification. Diagnoses of subjective cognitive ...

Your breast cancer pathology report is one of the most important documents you’ll get during the diagnostic process. It can be packed with information and may include many strange-sounding terms. If ...

PARIS--(BUSINESS WIRE)--Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the ...

Quest and Fierce 15 winner Paige have outlined revenue sharing and milestone agreements—plus arrangements for the clinical testing giant to use the resulting software in its own digital pathology ...